Boite à outils
Gala for GALenic Advanced
Gala platform is a technological plateau based on Innovation and Research, and was identified as a structuring project for the Cancer-Bio-Health cluster. The platform was originally created from a strategic partnership between Castres-Mazamet technopole and IMT Mines Albi, with a financing of investments from the agglomeration community of Castres-Mazamet, the Midi-Pyrénées Region and the State.
Gala platform is branch of the IMT Mines Albi school. Gala works in collaboration with 5 laboratories located in the Occitanie region to develop innovative technologies of galenic forms to target the sectors of health, chemistry, biotechnology, cosmetic, food and feed.
- A expertise network in the field, combining chemists, pharmacists, physics-chemists and engineers from five R&D laboratories: Rapsodee Center UMR CNRS 5302 of IMT Mines Albi; SPCMIB laboratory UMR 5068 CNRS/UPS; Chemistry engineering laboratory UMR 5503 CNRS/INPT; I.M.R.C.P. laboratory UMR 5623 CNRS/UPS (S.M.O.D.D. group) and CIRIMAT UMR 5085 CNRS/INPT/UPS (equiped « P.P.B. »);
- A technical laboratory of 400 square meters located at Castres (1h from Toulouse), devoted to materials generation process and galenic formulations, as well as materials characterisation. The platform gives a sharing of equipments to experiment and characterise process and materials in industrial conditions, also to manipulate pharmaceutical actives in the respect of the pharmaceutical safety rules.
A favoured collaboration between the 5 laboratories has been established to realise common researches; to give scientific services to external partners (industries, universities, others…); to develop the partenariats research of laboratories with thirds at local, national, aurorean and international levels.
Unify regional and local players with activities in galenic and materials generation process are closes;
Improve the connectivity between these different players;
Contribute to articulate the research in Occitanie Region;
Improve the visibility of the Cancer-Bio-Health competitiveness cluster;
Introduce collaborative projects between companies and/or laboratories, and tender from contracts in research;
Offer characterisation and research services within the Gala platform.